Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Geriatrics Reports
Erschienen in: Current Geriatrics Reports 3/2017

22.07.2017 | Nutrition, Obesity, and Diabetes (H Florez, Section Editor)

Prevention of Falls and Frailty in Older Adults with Diabetes

verfasst von: Helen P. Hazuda, Sara E. Espinoza

Erschienen in: Current Geriatrics Reports | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Type 2 diabetes mellitus (T2DM) is a major risk factor for falls and frailty in older adults. The purpose of this review was to survey, the current literature on risk factors and interventions for prevention of falls and frailty in older adults with T2DM.

Recent Findings

Screening for falls and frailty in the clinical setting is recommended. Exercise to improve balance, strength, and mobility; health education; and diabetes self-management are potential interventions for falls and frailty in older adults with T2DM. Pharmacologic agents are the focus of current studies which may lead to potential future interventions for both falls and frailty.

Summary

Evidence-based guidelines and tools for prevention and management of falls and frailty have been developed for clinicians caring for older adults. Because of the reciprocal relationship between falls and frailty, interventions to prevent one may also improve the other geriatric syndrome.
Literatur
1.
2.
3.
4.
5.
•• American Geriatrics Society. Falls. In: JE FJaL, editor. Geriatrics evaluation & management tools: clinical templates to support clinicians and systems that are caring for Older adults. New York, NY2015. Provides an evidence-based tool for falls screening and management in the clinical setting.
6.
7.
8.
• Yang Y, Hu X, Zhang Q, Zou R. Diabetes mellitus and risk of falls in older adults: a systematic review and meta-analysis. Age Ageing. 2016;45(6):761–7. doi:10.​1093/​ageing/​afw140. Identifies six prospective cohort studies conducted through November 2015 that have sufficient information to perform a meta-analysis to estimate the increased risk of falls in older adults with T2DM. PubMedCrossRef
9.
Pijpers E, Ferreira I, de Jongh RT, Deeg DJ, Lips P, Stehouwer CD, et al. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing. 2012;41(3):358–65. doi:10.​1093/​ageing/​afr145.PubMedCrossRef
10.
11.
12.
13.
14.
American Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society Guidelines for improving the care of older adults with diabetes mellitus: 2013 update. J Am Geriatr Soc. 2013;61(11):2020–6.PubMedCentralCrossRef
15.
16.
17.
18.
19.
20.
• Karmakar S, Rashidian H, Chan C, Liu C, Toth C. Investigating the role of neuropathic pain relief in decreasing gait variability in diabetes mellitus patients with neuropathic pain: a randomized, double-blind crossover trial. J Neuroeng Rehabil. 2014;11:125. doi:10.​1186/​1743-0003-11-125. Found that treatment of neuropathic pain with an analgesic drug rather than reducing the altered gait pattern of individuals with this condition resulted in increased gait variability, likely due to the potential adverse effects of analgesic drugs in increasing fall risk. PubMedPubMedCentralCrossRef
21.
Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–95. doi:10.​2337/​dc12-2480.PubMedPubMedCentralCrossRef
22.
23.
Signorovitch JE, Macaulay D, Diener M, Yan Y, Wu EQ, Gruenberger JB, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2013;15(4):335–41. doi:10.​1111/​dom.​12031.PubMedCrossRef
24.
25.
• Kachroo S, Kawabata H, Colilla S, Shi L, Zhao Y, Mukherjee J, et al. Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database. J Manag Care Spec Pharm. 2015;21(3):243–53. doi:10.​18553/​jmcp.​2015.​21.​3.​243. Well-designed study using a large US healthcare claims data base found that elderly patients with T2DM who had a hypoglycemic episode had a twofold increased risk of falls at 1 year following the episode compared to those with no hypoglycemic episodes. PubMedCrossRef
26.
Zhao Y, Kachroo S, Kawabata H, Colilla S, Mukherjee J, Fonseca V, et al. Association between hypoglycemia and fall-related fractures and health care utilization in older veterans with type 2 diabetes. Endocr Pract. 2016;22(2):196–204. doi:10.​4158/​EP15640.​OR.PubMedCrossRef
27.
Lu CL, Hsu PC, Shen HN, Chang YH, Chen HF, Li CY. Association between history of severe hypoglycemia and risk of falls in younger and older patients with diabetes. Medicine (Baltimore). 2015;94(33):e1339. doi:10.​1097/​MD.​0000000000001339​.CrossRef
28.
Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, et al. Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care. 2012;35(7):1525–31. doi:10.​2337/​dc11-2184.PubMedPubMedCentralCrossRef
29.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79. doi:10.​2337/​dc12-0413.PubMedPubMedCentralCrossRef
30.
31.
American Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc. 2011;59:148–57.CrossRef
32.
• Paton J, Glasser S, Collings R, Marsden J. Getting the right balance: insole design alters the static balance of people with diabetes and neuropathy. J Foot Ankle Res. 2016;9:40. doi:10.​1186/​s13047-016-0172-3. Calls attention to iatrogenic effects on postural instability and increased risk of falls associated with current off-loading footwear to relieve pain in diabetic ulcers. PubMedPubMedCentralCrossRef
33.
34.
35.
36.
Del Pozo-Cruz J, Alfonso-Rosa RM, Ugia JL, McVeigh JG, Pozo-Cruz BD, Sanudo B. A primary care-based randomized controlled trial of 12-week whole-body vibration for balance improvement in type 2 diabetes mellitus. Arch Phys Med Rehabil. 2013;94(11):2112–8. doi:10.​1016/​j.​apmr.​2013.​05.​030.PubMedCrossRef
37.
• Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. The lancet Diabetes & endocrinology. 2015;3(12):948–57. Demonstrates the potential for a novel pharmacological intervention to increase lean muscle mass and muscle power that may lead to its further development as a falls prevention intervention in weak older fallers. CrossRef
38.
• Centers for Disease Control and Prevention. STEADI—older adult fall prevention. https://​www.​cdc.​gov/​steadi. Accessed April 22 2017. Includes materials for providers’ older adult patients as well as provider training and continuing education. Of particular importance is the focus on modifiable risk factors for falls and specification of appropriate and effective interventions.
39.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults evidence for a phenotype. J Gerontol Ser A Biol Med Sci. 2001;56(3):M146–M57.CrossRef
40.
Cesari M, Prince M, Thiyagarajan JA, De Carvalho IA, Bernabei R, Chan P, et al. Frailty: an emerging public health priority. J Am Med Dir Assoc. 2016;17(3):188–92.CrossRefPubMed
41.
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5.PubMedCrossRef
42.
• Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R, et al. Frailty in older adults: a nationally representative profile in the United States. J Gerontol Ser A Biol Med Sci. 2015;70(11):1427–34. Characterized frailty in a large national study and reported on prevalence and outcomes. CrossRef
43.
Vaingankar JA, Chong SA, Abdin E, Picco L, Chua BY, Shafie S et al. Prevalence of frailty and its association with sociodemographic and clinical characteristics, and resource utilization in a population of Singaporean older adults. Geriatrics & Gerontology International. 2016.
44.
Castrejón-Pérez RC, Gutiérrez-Robledo LM, Cesari M, Pérez-Zepeda MU. Diabetes mellitus, hypertension and frailty: a population-based, cross-sectional study of Mexican older adults. Geriatr Gerontol Int. 2016;
45.
46.
Sinclair A, Dunning T, Rodriguez-Mañas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabet Endocrinol. 2015;3(4):275–85.CrossRef
47.
• Zaslavsky O, Woods NF, LaCroix AZ, Cauley JA, Johnson KC, Cochrane BB, et al. Identification of risk factors for mortality and poor-quality-of-life survival in frail older women participating in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2016;64(4):831–7. Diabetes was associated with increased mortality and poorer quality of life in older, frail women participants of the Women’s Health Initiative Observational Study. PubMedPubMedCentralCrossRef
48.
Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodríguez-Artalejo F, et al. Frailty as a major factor in the increased risk of death and disability in older people with diabetes. J Am Med Dir Assoc. 2016;17(10):949–55.PubMedCrossRef
49.
Kelaiditi E, Cesari M, Canevelli M, Van Kan GA, Ousset P-J, Gillette-Guyonnet S, et al. Cognitive frailty: rational and definition from an (IANA/IAGG) international consensus group. J Nutr Health Aging. 2013;17(9):726–34.PubMedCrossRef
50.
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol Ser A Biol Med Sci. 2007;62(7):722–7.CrossRef
51.
Li J, Nie S, Wang S, Li Y, Zou Y, Jing X, et al. Operationalization of frailty index in diabetic older patients. J Am Med Dir Assoc. 2016;17(3):273.PubMedCrossRef
52.
Jones DM, Song X, Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc. 2004;52(11):1929–33.PubMedCrossRef
53.
Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–7.PubMedCrossRef
54.
• Cesari M, Gambassi G, van Kan GA, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2. Discussion of the differences between Fried frailty phenotype and Rockwood frailty index and suggestion for application in the clinical setting for frailty screening. PubMedCrossRef
55.
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333–41.PubMedCrossRef
56.
Shamsi KS, Pierce A, Ashton AS, Halade DG, Richardson A, Espinoza SE. Proteomic screening of glycoproteins in human plasma for frailty biomarkers. J Gerontol Ser A Biol Med Sci. 2012;67(8):853–64.CrossRef
57.
Darvin K, Randolph A, Ovalles S, Halade D, Breeding L, Richardson A et al. Plasma protein biomarkers of the geriatric syndrome of frailty. J Geront Ser A Biol Sci Med Sci. 2013:glt183.
58.
Baylis D, Bartlett D, Syddall H, Ntani G, Gale C, Cooper C, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age. 2013;35(3):963–71.PubMedCrossRef
59.
Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2007;167(7):635–41.PubMedCrossRef
60.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.CrossRefPubMed
61.
• Mohler MJ, Fain MJ, Wertheimer AM, Najafi B, Nikolich-Žugich J. The Frailty syndrome: clinical measurements and basic underpinnings in humans and animals. Exp Gerontol. 2014;54:6–13. Review and discussion of current basic and translational research relative to the geriatric syndrome of frailty. PubMedCrossRef
62.
63.
Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP. The association between obesity and the frailty syndrome in older women: the Women’s Health and Aging Studies. J Am Geriatr Soc. 2005;53(6):927–34.PubMedCrossRef
64.
Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol Ser A Biol Med Sci. 2010;65(4):377–81.CrossRef
65.
Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014;15(12):853–9.PubMedCrossRef
66.
Espinoza SE, Jung I, Hazuda H. Lower frailty incidence in older Mexican Americans than in older European Americans: the San Antonio longitudinal study of aging. J Am Geriatr Soc. 2010;58(11):2142–8.PubMedPubMedCentralCrossRef
67.
de Souza MB, Ferreira Sampaio R, Rossana Cavalcanti Furtado S, Correa Dias R, Noce Kirkwood R. The relationship between diabetes mellitus, geriatric syndromes, physical function, and gait: a review of the literature. Curr Diabetes Rev. 2016;12(3):240–51.CrossRef
68.
• García-Esquinas E, Graciani A, Guallar-Castillón P, López-García E, Rodríguez-Mañas L, Rodríguez-Artalejo F. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc. 2015;16(9):748–54. Type 2 diabetes was associated with over twice the odds of incident frailty in community-dwelling older adults, which was partially explained by obesity, unhealthy lifestyle habits, poor glycemic control, and altered lipid profile. PubMedCrossRef
69.
Fugate Woods N, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53(8):1321–30.CrossRef
70.
Lee JS, Auyeung T-W, Leung J, Kwok T, Woo J. Transitions in frailty states among community-living older adults and their associated factors. J Am Med Dir Assoc. 2014;15(4):281–6.PubMedCrossRef
71.
Bouillon K, Kivimäki M, Hamer M, Shipley MJ, Akbaraly TN, Tabak A, et al. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study. J Am Med Dir Assoc. 2013;14(11):851. e1–6.CrossRef
72.
Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabet Endocrinol. 2014;2(10):819–29.CrossRef
73.
Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care. 2015;38(1):82–90.PubMedCrossRef
74.
Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabet Metab J. 2016;40(3):182–9.CrossRef
75.
Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus. Geriatrics & gerontology international. 2016.
76.
Sinclair AJ, Rodriguez-Mañas L. Diabetes and frailty: two converging conditions? Can J Diabetes. 2016;40(1):77–83.PubMedCrossRef
77.
Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes. Diabetes. 2006;55(6):1813–8.PubMedCrossRef
78.
Wang C-P, Hazuda HP. Better glycemic control is associated with maintenance of lower-extremity function over time in Mexican American and European American older adults with diabetes. Diabetes Care. 2011;34(2):268–73.PubMedPubMedCentralCrossRef
79.
Kalyani RR, Tra Y, Yeh HC, Egan JM, Ferrucci L, Brancati FL. Quadriceps strength, quadriceps power, and gait speed in older US adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999–2002. J Am Geriatr Soc. 2013;61(5):769–75.PubMedPubMedCentralCrossRef
80.
• Zaslavsky O, Walker RL, Crane PK, Gray SL, Larson EB. Glucose levels and risk of frailty. J Gerontol Ser A Biol Sci Med Sci. 2016:glw024. Hyperglycemia increased risk for incident frailty in older adults without diabetes but with higher than normal fasting glucose levels, suggesting that pre-diabetes is a risk factor for frailty.
81.
Espinoza SE, Jung I, Hazuda H. The Hispanic paradox and predictors of mortality in an aging biethnic cohort of Mexican Americans and European Americans: the san antonio longitudinal study of aging. J Am Geriatr Soc. 2013;61(9):1522–9.PubMedPubMedCentralCrossRef
82.
Lee JS, Auyeung T-W, Leung J, Kwok T, Leung P-C, Woo J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging. 2011;15(10):857–62.PubMedCrossRef
83.
Rodríguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement. The frailty operative definition-consensus conference project. J Gerontol Ser A Biol Med Sci. 2013;68(1):62–7.CrossRef
84.
85.
Hoogendijk EO, van der Horst HE, Deeg DJH, Frijters DHM, Prins BAH, Jansen APD, et al. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013;42(2):262–5. doi:10.​1093/​ageing/​afs163.PubMedCrossRef
86.
van Kan GA, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275–86.CrossRef
87.
•• American Geriatrics Society. Frailty. In: Talebreza S, editor. Geriatrics evaluation & management tools: clinical templates to support clinicians and systems that are caring for older adults. New York, NY: American Geriatrics Society; 2015. Provides an evidence-based tool for frailty screening and management in the clinical setting.
88.
Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2014:afu157.
89.
Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52(4):625–34.PubMedCrossRef
90.
Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–7.PubMedPubMedCentralCrossRef
91.
Bibas L, Levi M, Bendayan M, Mullie L, Forman DE, Afilalo J. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis. 2014;57(2):134–43.PubMedCrossRef
92.
Bendayan M, Bibas L, Levi M, Mullie L, Forman DE, Afilalo J. Therapeutic interventions for frail elderly patients: part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis. 2014;57(2):144–51.PubMedCrossRef
93.
Cameron ID, Fairhall N, Langron C, Lockwood K, Monaghan N, Aggar C, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med. 2013;11(1):65.PubMedPubMedCentralCrossRef
94.
Starr KNP, McDonald SR, Bales CW. Obesity and physical frailty in older adults: a scoping review of lifestyle intervention trials. J Am Med Dir Assoc. 2014;15(4):240–50.CrossRef
95.
Cameron ID, Nicola F, Gill, Liz; Lockwood, Keri, Langron, Colleen, Aggar, Christina, Monaghan, Noeline, Kurrle, Susan;. Developing interventions for frailty. Advances in Geriatrics. 2015;2015.CrossRef
96.
Association AD. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Supplement 1):S14–80.CrossRef
97.
Theou O, Stathokostas L, Roland KP, Jakobi JM, Patterson C, Vandervoort AA, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. Journal of aging research. 2011;2011
98.
• Cesari M, Vellas B, Hsu F-C, Newman AB, Doss H, King AC, et al. A physical activity intervention to treat the frailty syndrome in older persons—results from the LIFE-P study. J Gerontol Ser A Biol Med Sci. 2015;70(2):216–22. Results from a large clinical trial of exercise in older adults with sedentary lifestyle demonstrating reduction in frailty. CrossRef
99.
• Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218–29. doi:10.​1056/​NEJMoa1008234. A small, but important randomized controlled trial showing that an intervention with a combination of weight loss and exercise produces greater improvement in physical function and reduced frailty than an intervention utilizing either weight loss or exercise alone. PubMedPubMedCentralCrossRef
100.
• Rejeski WJ, Ip EH, Bertoni AG, Bray GA, Evans G, Gregg EW, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366(13):1209–17. doi:10.​1056/​NEJMoa1110294. A large multicenter, randomized controlled trial showing that at the end of 4 years, an ILI intervention group compared to a DSE control group had a 48% reduction in risk of loss of mobility. Importantly, mediation analysis showed that both weight loss and improved fitness were significant mediators of this effect. PubMedPubMedCentralCrossRef
101.
Fairhall N, Sherrington C, Kurrle SE, Lord SR, Lockwood K, Cameron ID. Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial. BMC Med. 2012;10(1):120.PubMedPubMedCentralCrossRef
102.
Norris SL, Engelgau MM, Narayan KV. Effectiveness of self-management training in type 2 diabetes. Diabetes Care. 2001;24(3):561–87.PubMedCrossRef
103.
Pariser G, Hager K, Gillette P, Golemboski K, Jackson K. Active steps for diabetes a community-campus partnership addressing frailty and diabetes. Diabet Educ. 2014;40(1):60–7.CrossRef
104.
Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104–15.PubMedCrossRef
105.
Nair KS, Rizza RA, O'brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355(16):1647–59.PubMedCrossRef
106.
Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S. Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol. 2013;9(7):414–24.PubMedCrossRef
107.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–59.PubMedCrossRef
108.
• Cesari M, Fielding R, Bénichou O, Bernabei R, Bhasin S, Guralnik J, et al. Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force. J Frailty Aging. 2015;4(3):114. Results from a recent meeting of the International Conference on Frailty and Sarcopenia Task Force, which provides update on translational research on pharmacological interventions for frailty. PubMedPubMedCentral
109.
Dam T-T, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol Ser A Biol Med Sci. 2014;69(5):584–90.CrossRef
110.
Vellas B, Fielding R, Bhasin S, Cerreta F, Goodpaster B, Guralnik J, et al. Sarcopenia trials in specific diseases: report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2016;5(4):194.PubMed
111.
Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006;166(4):418–23.PubMedCrossRef
112.
Cadore EL, Casas-Herrero A, Zambom-Ferraresi F, Idoate F, Millor N, Gómez M, et al. Multicomponent exercises including muscle power training enhance muscle mass, power output, and functional outcomes in institutionalized frail nonagenarians. Age. 2014;36(2):773–85.PubMedCrossRef
113.
Fiatarone MA, O'neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769–75.PubMedCrossRef
Metadaten
Titel
Prevention of Falls and Frailty in Older Adults with Diabetes
verfasst von
Helen P. Hazuda
Sara E. Espinoza
Publikationsdatum
22.07.2017
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 3/2017
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-017-0209-x

Weitere Artikel der Ausgabe 3/2017

Current Geriatrics Reports 3/2017 Zur Ausgabe

Surgical Care for the Geriatric Patient (F Luchette and R Gonzalez, Section Editors)

Anesthesia Considerations for the Geriatric Patient

Nutrition, Obesity, and Diabetes (H Florez, Section Editor)

Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes

Nutrition, Obesity, and Diabetes (H Florez, Section Editor)

Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes

Erratum

Erratum to: Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes

Surgical Care for the Geriatric Patient (F Luchette and R Gonzalez, Section Editors)

Thoracic Surgery in Older Patients

Nutrition, Obesity, and Diabetes (H Florez, Section Editor)

Impact of Geriatric Syndromes on Diabetes Management

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise